SUMMARY. The dataset is full of gaps, it’s unclear what the MHRA Expert Working Group based their decisions on and it’s all secret. But everything else is OK
We continue reviewing the minutes of the meetings of the MHRA’s Commission On Human Medicines (CHM) COVID-19 Vaccines Benefit Risk Expert Working Group, which took place between 20 and 27 November…